psychedelics

Havn Life Sciences Ivan Casselman Casselman

Havn Life Sciences chief psychedelic officer marries love of plants with desire to help

Dr. Ivan Casselman says he has been setting himself up to work in the psychedelic industry for quite some time.

0
ptsd-psilocin

Enhancer boosts psilocin potential in psychedelic therapy to treat PTSD

Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.

0
Father-John-Misty

Remembering that time Father John Misty told me about his psychedelic experiences

Father John Misty doesn’t make psychedelic music per se. What it may lack in acid-rock trappings, it makes up for with insights the artist attributes to his drug trips

0
PTSD

MDMA shows potential in PTSD treatment; more research needed on other psychedelics

Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder

0
Berkeley-shrooms

UC Berkeley is launching a new centre for psychedelic research

The centre’s cofounders include UC Berkeley neuroscientist David Presti, psychologist Dacher Keltner, and journalism professor Michael Pollan

0

New LSD research shows promise of pain relief without a psychedelic trip

The controlled clinical experiment constitutes the first study in a long time to revisit the potential of LSD as an analgesic

0
psychedelic-science

The real promise of LSD, MDMA, and mushrooms for medical science

Therapeutic breakthroughs suggest that the historical reputation of psychedelics as dangerous has unfairly overshadowed a more optimistic interpretation

0
psychedelics-research

NDP health critic Don Davies backs psychedelics research

Health Canada allows certain companies to conduct research on drugs

0
psilocybin-access

Palliative patients await August 4 Canadian government decision on psilocybin access

Four patients battling cancer seek psilocybin-assisted psychotherapy

0